A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection

NCT06008860 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

280

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Experimental: Primary Cohort
OTHER: Placebo Comparator: Primary Cohort - Placebo

Sponsor

University of Chicago